Chinese regulators have used informal window guidance to hold back a wave of humanoid robot listings, Reuters reported on 21 September, after Unitree Robotics, which had surged more than five-fold on its Shanghai debut a month earlier, slumped 55 percent from that peak. Mech-Mind Robotics, which listed on 1 September, is down nearly 20 percent from its own debut. Neither company has been formally barred from anything, but people familiar with the reviews describe humanoid IPOs as effectively frozen for now.
The concern is revenue quality, not just share price. Private-market valuations across the sector have already been cut 30 to 50 percent, and regulators are examining whether they could fall a further 60 to 70 percent if revenue tied to government-backed data-collection centres were stripped out of the numbers. Mech-Mind’s own chief executive, Shao Tianlan, alleged in a WeChat post this month that some highly valued embodied-AI firms are generating revenue through data-collection centres and related-party deals rather than independent commercial sales.
Deep Robotics, X Square Robot and AGIBOT are named alongside Unitree and Mech-Mind as companies caught in the slowdown. It follows a year in which mainland Chinese firms raised $148.9 billion through share sales, up 59 percent from a year earlier, with technology companies accounting for a large share of that total. One venture capitalist quoted by Reuters described the rush into humanoid robotics as campaign-style innovation, investors chasing a policy-favoured sector rather than proven demand.
No formal ban means the freeze could lift as quickly as it appeared, and regulators have not said what share of a company’s revenue they will ultimately accept as genuinely commercial versus state-subsidised. Every company mid-review is left pricing its own IPO against a standard nobody has published yet.
